V Fedirko1, I Tramacere2, V Bagnardi3, M Rota4, L Scotti5, F Islami6, E Negri2, K Straif7, I Romieu7, C La Vecchia8, P Boffetta9, M Jenab7. 1. International Agency for Research on Cancer, Lyon, France. Electronic address: fedirkov@fellows.iarc.fr. 2. Istituto di Ricerche Farmacologiche 'Mario Negri', Milan, Italy. 3. Department of Statistics, University of Milano-Bicocca, Milan, Italy; Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. 4. Department of Statistics, University of Milano-Bicocca, Milan, Italy; Department of Clinical Medicine and Prevention, Centre of Biostatistics for Clinical Epidemiology, University of Milano-Bicocca, Monza, Italy. 5. Department of Statistics, University of Milano-Bicocca, Milan, Italy. 6. International Agency for Research on Cancer, Lyon, France; Digestive Disease Research Center, Shariati Hospital, Tehran University of Medical sciences, Tehran, Iran; King's College London, Thames Cancer Registry, London, UK. 7. International Agency for Research on Cancer, Lyon, France. 8. Istituto di Ricerche Farmacologiche 'Mario Negri', Milan, Italy; Section of Medical Statistics, Department of Occupational Health, Università degli Studi di Milano, Milan, Italy. 9. The Tisch Cancer Institute, Mount Sinai School of Medicine, New York, NY, USA; International Prevention Research Institute, Lyon, France.
Abstract
BACKGROUND: The International Agency for Research on Cancer (IARC) concluded that alcohol consumption is related to colorectal cancer (CRC). However, several issues remain unresolved, including quantification of the association for light (≤1 drink/day) and moderate (2-3 drinks/day) alcohol drinking, investigation of the dose-response relationship, and potential heterogeneity of effects by sex, colorectal site, and geographical region. METHODS: Twenty-seven cohort and 34 case-control studies presenting results for at least three categories of alcohol intake were identified from a PubMed search of articles published before May 2010. The summary relative risks (RRs) were estimated by the random effects model. Second-order fractional polynomials and random effects meta-regression models were used for modeling the dose-risk relation. RESULTS: The RRs were 1.21 [95% confidence interval (CI) 1.13-1.28] for moderate and 1.52 (95% CI 1.27-1.81) for heavy (≥4 drinks/day) alcohol drinking. The RR for moderate drinkers, compared with non-/occasional drinkers, was stronger for men (RR = 1.24, 95% CI 1.13-1.37) than for women (RR = 1.08, 95% CI 1.03-1.13; P(heterogeneity) = 0.02). For heavy drinkers, the association was stronger in Asian studies (RR = 1.81, 95% CI 1.33-2.46; P(heterogeneity) = 0.04). The dose-risk analysis estimated RRs of 1.07 (95% CI 1.04-1.10), 1.38 (95% CI 1.28-1.50), and 1.82 (95% CI 1.41-2.35) for 10, 50, and 100 g/day of alcohol, respectively. CONCLUSIONS: This meta-analysis provides strong evidence for an association between alcohol drinking of >1 drink/day and colorectal cancer risk.
BACKGROUND: The International Agency for Research on Cancer (IARC) concluded that alcohol consumption is related to colorectal cancer (CRC). However, several issues remain unresolved, including quantification of the association for light (≤1 drink/day) and moderate (2-3 drinks/day) alcohol drinking, investigation of the dose-response relationship, and potential heterogeneity of effects by sex, colorectal site, and geographical region. METHODS: Twenty-seven cohort and 34 case-control studies presenting results for at least three categories of alcohol intake were identified from a PubMed search of articles published before May 2010. The summary relative risks (RRs) were estimated by the random effects model. Second-order fractional polynomials and random effects meta-regression models were used for modeling the dose-risk relation. RESULTS: The RRs were 1.21 [95% confidence interval (CI) 1.13-1.28] for moderate and 1.52 (95% CI 1.27-1.81) for heavy (≥4 drinks/day) alcohol drinking. The RR for moderate drinkers, compared with non-/occasional drinkers, was stronger for men (RR = 1.24, 95% CI 1.13-1.37) than for women (RR = 1.08, 95% CI 1.03-1.13; P(heterogeneity) = 0.02). For heavy drinkers, the association was stronger in Asian studies (RR = 1.81, 95% CI 1.33-2.46; P(heterogeneity) = 0.04). The dose-risk analysis estimated RRs of 1.07 (95% CI 1.04-1.10), 1.38 (95% CI 1.28-1.50), and 1.82 (95% CI 1.41-2.35) for 10, 50, and 100 g/day of alcohol, respectively. CONCLUSIONS: This meta-analysis provides strong evidence for an association between alcohol drinking of >1 drink/day and colorectal cancer risk.
Authors: David A Drew; Madeline M Schuck; Marina V Magicheva-Gupta; Kathleen O Stewart; Katherine K Gilpin; Patrick Miller; Melanie P Parziale; Emily N Pond; Oliver Takacsi-Nagy; Dylan C Zerjav; Samantha M Chin; Jennifer Mackinnon Krems; Dana Meixell; Amit D Joshi; Wenjie Ma; Francis P Colizzo; Peter J Carolan; Norman S Nishioka; Kyle Staller; James M Richter; Hamed Khalili; Manish K Gala; John J Garber; Daniel C Chung; Joseph C Yarze; Lawrence Zukerberg; Giovanna Petrucci; Bianca Rocca; Carlo Patrono; Ginger L Milne; Molin Wang; Andrew T Chan Journal: Cancer Prev Res (Phila) Date: 2020-07-27
Authors: Joshua Petimar; Stephanie A Smith-Warner; Bernard Rosner; Andrew T Chan; Edward L Giovannucci; Fred K Tabung Journal: Cancer Epidemiol Biomarkers Prev Date: 2019-06-24 Impact factor: 4.254
Authors: Faraz Bishehsari; Lijuan Zhang; Robin M Voigt; Natalie Maltby; Bita Semsarieh; Eyas Zorub; Maliha Shaikh; Sherry Wilber; Andrew R Armstrong; Seyed Sina Mirbagheri; Nailliw Z Preite; Peter Song; Alessia Stornetta; Silvia Balbo; Christopher B Forsyth; Ali Keshavarzian Journal: Alcohol Clin Exp Res Date: 2019-07-22 Impact factor: 3.455
Authors: Phyo T Htoo; John B Buse; Mugdha Gokhale; M Alison Marquis; Virginia Pate; Til Stürmer Journal: Eur J Clin Pharmacol Date: 2016-05-10 Impact factor: 2.953